These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 21878661
1. Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD. Saito Y, Tanaka Y, Aita Y, Ishii KA, Ikeda T, Isobe K, Kawakami Y, Shimano H, Hara H, Takekoshi K. Am J Physiol Endocrinol Metab; 2012 Mar 15; 302(6):E615-25. PubMed ID: 21878661 [Abstract] [Full Text] [Related]
7. Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway. Ping SY, Wu CL, Yu DS. Urol Oncol; 2012 Sep 15; 30(5):652-9. PubMed ID: 20884251 [Abstract] [Full Text] [Related]
8. Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways. Yang F, Jove V, Xin H, Hedvat M, Van Meter TE, Yu H. Mol Cancer Res; 2010 Jan 15; 8(1):35-45. PubMed ID: 20053726 [Abstract] [Full Text] [Related]
11. Butyrate inhibits the proliferation and induces the apoptosis of colorectal cancer HCT116 cells via the deactivation of mTOR/S6K1 signaling mediated partly by SIRT1 downregulation. Cao M, Zhang Z, Han S, Lu X. Mol Med Rep; 2019 May 15; 19(5):3941-3947. PubMed ID: 30864709 [Abstract] [Full Text] [Related]
13. [Sunitinib induces autophagy via suppressing Akt/mTOR pathway in renal cell carcinoma]. Cao P, Jiang XJ, Xi ZJ. Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug 18; 48(4):584-589. PubMed ID: 29263493 [Abstract] [Full Text] [Related]
14. Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor. Xie C, Wan X, Quan H, Zheng M, Fu L, Li Y, Lou L. Cancer Sci; 2018 Apr 18; 109(4):1207-1219. PubMed ID: 29446853 [Abstract] [Full Text] [Related]
15. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment. Hatipoglu G, Hock SW, Weiss R, Fan Z, Sehm T, Ghoochani A, Buchfelder M, Savaskan NE, Eyüpoglu IY. Cancer Sci; 2015 Feb 18; 106(2):160-70. PubMed ID: 25458015 [Abstract] [Full Text] [Related]
16. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models. Wu XY, Xu H, Wu ZF, Chen C, Liu JY, Wu GN, Yao XQ, Liu FK, Li G, Shen L. Oncotarget; 2015 Dec 29; 6(42):44563-78. PubMed ID: 26575424 [Abstract] [Full Text] [Related]
17. Crosstalk between VEGFR2 and muscarinic receptors regulates the mTOR pathway in serum starved SK-N-SH human neuroblastoma cells. Edelstein J, Hao T, Cao Q, Morales L, Rockwell P. Cell Signal; 2011 Jan 29; 23(1):239-48. PubMed ID: 20851763 [Abstract] [Full Text] [Related]
18. ZD6474 induces growth arrest and apoptosis of GIST-T1 cells, which is enhanced by concomitant use of sunitinib. Yang Y, Ikezoe T, Nishioka C, Taguchi T, Zhu WG, Koeffler HP, Taguchi H. Cancer Sci; 2006 Dec 29; 97(12):1404-9. PubMed ID: 16995874 [Abstract] [Full Text] [Related]
19. Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Chinni SR, Sarkar FH. Clin Cancer Res; 2002 Apr 29; 8(4):1228-36. PubMed ID: 11948137 [Abstract] [Full Text] [Related]
20. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells. Doi Y, Yashiro M, Yamada N, Amano R, Noda S, Hirakawa K. Ann Surg Oncol; 2012 Aug 29; 19(8):2733-43. PubMed ID: 22207048 [Abstract] [Full Text] [Related] Page: [Next] [New Search]